Hyperion Partners’s Merck MRK Stock Holding History

Hyperion Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,787	Closed	-$221K	–	76
2024 Q2	$221K	Buy	1,787 +193	+12%	+$24.9K	0.16%	63
2024 Q1	$210K	Buy	+1,594	New	+$196K	0.15%	66

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hyperion Partners's MRK Position: Q3 2024 in Review

Hyperion Partners sold out of Merck (MRK) in Q3 2024, closing a stake of 1,787 shares — an estimated $221K sold.

Hyperion Partners first reported a position in MRK in Q1 2024 and held it in 2 quarters. The position peaked at $221K in Q2 2024. 3,496 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Hyperion Partners reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Hyperion Partners sold 1,787 Merck shares in Q3 2024, an estimated $221K.
Hyperion Partners first reported a position in Merck in Q1 2024 and held it in 2 quarters.
Hyperion Partners's Merck position peaked at $221K in Q2 2024.
3,496 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Hyperion Partners's 13F filing for Q3 2024, filed 9 Oct 2024.